Hudson Bay Capital Management
OLMA icon

Hudson Bay Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Hudson Bay Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.09M Buy
566,400
+411,630
+266% +$5.51M 0.02% 459
2026
Q1 		$2.31M Buy
+154,770
New +$3.45M 0.01% 734
2024
Q2 		– Sell
-67,507
Closed -$764K – 895
2024
Q1 		$764K Buy
67,507
+5,007
+8% +$64.6K ﹤0.01% 562
2023
Q4 		$877K Buy
+62,500
New +$840K 0.01% 530

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Hudson Bay Capital Management's OLMA Position: Q2 2026 in Review

Hudson Bay Capital Management increased its Olema Pharmaceuticals (OLMA) stake by 266% in Q2 2026, buying an estimated $5.51M and bringing the position to 566,400 shares worth $7.09M. The position accounts for 0.02% of the portfolio, ranked #459.

Hudson Bay Capital Management first reported a position in OLMA in Q4 2023 and has held it in 4 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Hudson Bay Capital Management held 566,400 shares of Olema Pharmaceuticals worth $7.09M as of Q2 2026.
  • Hudson Bay Capital Management bought 411,630 Olema Pharmaceuticals shares in Q2 2026, an estimated $5.51M.
  • Olema Pharmaceuticals made up 0.02% of Hudson Bay Capital Management's portfolio in Q2 2026, its #459 holding.
  • Hudson Bay Capital Management first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.